Arbutus Biopharma Corp (NASDAQ:ABUS)

2.90
BATS BZX Real-Time Price
As of 10:30am ET
 -0.205 / -6.61%
Today’s Change
0.82
Today|||52-Week Range
4.75
+4.14%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$201.9M

Company Description

Arbutus Biopharma Corp. engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company is headquartered in Burnaby, Canada.

Contact Information

Arbutus Biopharma Corp.
8900 Glenlyon Parkway
Burnaby British Columbia V5J 5J8
P:(604) 419-3200
Investor Relations:

Employees

Shareholders

Individual stakeholders32.52%
Mutual fund holders3.76%
Other institutional29.34%

Top Executives

There are no executives to display.